Harvey Lodish|Harvey Lodish

Member, Whitehead Institute for Biomedical Research, Whitehead Institute; Professor of Biology and Professor of Bioengineering, Massachusetts Institute of Technology

Dr. Lodish received his A.B. degree summa cum laude in chemistry and mathematics fromKenyon Collegein 1962 and his Ph.D. degree in genetics from theRockefeller Universityin 1966. Following two years of postdoctoral research at theMRC Laboratory of Molecular Biologywith Drs. Sydney Brenner and Francis Crick, he joined the faculty of theMITDepartment of Biology. He was promoted to professor in 1976, and in 1983 was appointed founding member of theWhitehead Institute for Biomedical Research. In 1999, he also became Professor of Biological Engineering in the newMIT Department of Biological Engineering.

He was elected a fellow of theAmerican Association for the Advancement of Sciencein 1986, a member of the国家nal Academy of Sciencesin 1987, and a fellow of theAmerican Academy of Arts and Sciencesin 1999. He is a member of the Board of Trustees of Boston Children's Hospital, where from 2007 to 2019 he chaired the Board Research Committee. He is also the lead author of the textbookMolecular Cell Biology; the ninth edition was published in late 2020. During the 2004 calendar year, he served as President of theAmerican Society for Cell Biology. Dr. Lodish was a founder and scientific advisory board member of several biotech companies including Genzyme Inc., Millennium Pharmaceuticals, and Rubius Therapeutics. From 2008 to 2015, he served as the founding chair of the Scientific Advisory Board of theMassachusetts Life Sciences Center, the group charged with oversight of the state's 10-year, $1 billion investment in the life sciences.

Over 200 MD, PhD, and MD/PhD students and fellows have trained in his laboratory; two of his trainees have received the Nobel Prize and eight have been elected to the U.S. National Academy of Sciences or the国家nal Academy of Medicine.